Collectively, DIM alleviates hepatic lipid accumulation and oxidative stress in MASLD models through AMPK activation, subsequently modulating PPARα and SREBP1/ACC1 pathways. This evidence concerns the gene SREBF1 and metabolic dysfunction-associated steatotic liver disease.